alexa Anti-Hemophilic-Factor-viii|omicsgroup|Journal Of Biotechnology And Biomaterials

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Anti-Hemophilic-Factor-viii

Pharmaceutical recombinant proteins such as growth hormone, insulin and anti-hemophilic factor VIII were commonly expressed and overproduced in microorganisms such as E. coli. Since the over expression of genes in foreign hosts may form inclusion bodies, further treatments on the secreted proteins are required, including unfolding and refolding processes. Genetic engineering can also be used to increase protein stability. Studying the structural properties and folding processes, Mirzahoseini and Alibolandi investigated the effect of chaperones as heat shock proteins on human basic fibroblast growth factor stability. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014

Top